Cataract Surgery With Intracameral Triamcinolone in Infants
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the present study is to investigate the outcomes of congenital cataract surgery
when injecting intraoperative intracameral triamcinolone versus the postoperative use of oral
prednisolone.
This is a prospective, randomized clinical trial. Sixty children will be submitted to
congenital cataract surgery younger than 2 years of age. They will be randomly divided in two
groups. The study group will receive an intraoperative intracameral triamcinolone acetonide
injection. The control group will receive prednisolone syrup postoperatively. The surgical
outcomes will be assessed after one year.